12:00 AM
 | 
Feb 04, 2013
 |  BC Week In Review  |  Company News  |  Other News

Novartis cardiovascular news

In its 4Q12 earnings, Novartis said it received a subpoena from the U.S. Attorney's Office for the Western District of Kentucky seeking documents related to the company's marketing of Tekturna aliskiren and aliskiren-containing combination...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >